The FDA has expanded its emergency use authorization for Regeneron's COVID-19 antibody cocktail.
Aug 2, 2021 -- The U.S. Food and Drug Administration on Friday expanded its emergency use authorization for the antibody cocktail from Regeneron, making it the first preventive therapy authorized for unvaccinated and immunocompromised people in high-risk settings.
“This authorization enables these groups to use REGEN-COV to prevent infection in post-exposure and certain institutional settings,” Regeneron said in a"Today's FDA authorization enables certain people at high risk of developing severe COVID-19 infection to access REGEN-COV if they have been exposed to the virus – the first time an antibody treatment has been authorized for this purpose," said George D. Yancopoulos, M.D., president and chief scientific officer of Regeneron.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA Under Pressure to Grant Full Approval to Covid-19 VaccinesAdvisers to the FDA and former officials predict that full approval of Pfizer’s Covid-19 vaccine—currently authorized for emergency use—could come in September or October
Weiterlesen »
Women seeking medication abortions face increasing state restrictions as FDA weighs action“Over the past year, we've seen states really target medication abortion in a way that we hadn't seen,' Elizabeth Nash, of the Guttmacher Institute, said.
Weiterlesen »
mRNA's Next Chapter Has Nothing to Do With COVID-19 VaccinesMRNA's Next Chapter Has Nothing to Do With COVID-19 Vaccines
Weiterlesen »
FDA Under Pressure to Grant Full Approval to Covid-19 VaccinesAdvisers to the FDA and former officials predict that full approval of Pfizer’s Covid-19 vaccine—currently authorized for emergency use—could come in September or October
Weiterlesen »
Almost Every Doctor Recommends Sunscreen. So Why Don't We Know More About Its Safety?Stronger FDA regulations could change that
Weiterlesen »
Women seeking medication abortions face increasing state restrictions as FDA weighs action“Over the past year, we've seen states really target medication abortion in a way that we hadn't seen,' Elizabeth Nash, of the Guttmacher Institute, said.
Weiterlesen »